希腊孕妇对B族链球菌疫苗的知识、认知与接种意愿:横断面研究
研究在希腊西北部一家三级医院对421名产检孕妇进行横断面调查,评估其对B族链球菌(GBS)的知识、疫苗安全性与有效性认知及未来接种意愿。结果显示GBS总体知晓率68.9%,未来GBS疫苗接种意愿为49.9%。多因素分析显示较高教育水平、知晓预防措施、妊娠并发症及既往Tdap接种与接种意愿增加相关,而担心长期不良反应、认为影响母乳喂养及IVF受孕与意愿降低相关。
要点
- 孕妇对GBS总体知晓率68.9%,对预防措施、新生儿后果及产前检测的知晓率更低。
- 未来GBS疫苗接种意愿为49.9%,安全感知、母乳喂养顾虑及既往 maternal 疫苗接种影响意愿。
- 加强沟通、统一提供者信息及针对特定亚组支持可能有助于孕产妇GBS疫苗接种实施。
核心结论
- 尽管GBS知晓率有限,近半数孕妇表示愿意接种未来GBS疫苗。
- 接种意愿受安全感知、母乳喂养顾虑及既往孕产妇疫苗接种影响。
研究设计与样本
- 共421名孕妇参与,使用结构化自填问卷评估GBS知识、预防措施认知、疫苗安全与母乳喂养信念、既往孕产妇疫苗接种及未来GBS疫苗接种意愿。
- 采用描述性统计、卡方检验和二元logistic回归识别疫苗接受预测因素。
主要发现
- GBS总体知晓率为68.9%。
- 对未来GBS疫苗的接种意愿为49.9%。
- 多因素分析中,较高教育水平、知晓预防措施、妊娠并发症及既往Tdap接种与接种接受度增加相关。
- 担心长期不良反应、认为影响母乳喂养及IVF受孕与接种接受度降低相关。
临床怎么用
- 应加强GBS相关沟通和提供者一致信息,以提升孕妇认知与疫苗接受度。
- 针对担心长期不良反应、母乳喂养顾虑及IVF受孕等亚组提供针对性支持。
- 可将既往孕产妇疫苗接种史作为识别接种意愿较低人群的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Group B Streptococcus (GBS) is a major cause of neonatal morbidity and mortality. As maternal GBS vaccines progress toward licensure, understanding the determinants of acceptance is essential. This study assessed pregnant women's knowledge of GBS, perceptions of vaccine safety and effectiveness, and intention to receive a future maternal GBS vaccine in Greece. METHODS: A cross-sectional survey was conducted among pregnant women attending routine antenatal care at a tertiary hospital in Northwest Greece (July-November 2025). A structured, self-administered questionnaire assessed GBS knowledge, awareness of preventive measures, beliefs regarding vaccine safety and breastfeeding, prior maternal vaccination, and intention to receive a future GBS vaccine. Descriptive statistics, chi-square tests, and binary logistic regression were used to identify predictors of vaccine acceptance. RESULTS: A total of 421 women participated. General awareness of GBS was moderate (68.9%), while awareness of preventive measures, neonatal consequences, and prenatal testing was lower. Intention to accept a future GBS vaccine was evenly divided (49.9%). In multivariable analysis, higher educational level, awareness of preventive measures, pregnancy complications, and prior Tdap vaccination were associated with increased acceptance. Concerns about long-term adverse effects, perceived impact on breastfeeding, and conception via IVF were associated with reduced acceptance. CONCLUSIONS: Despite limited GBS awareness, nearly half of pregnant women expressed willingness to receive a future GBS vaccine. Acceptance was shaped by safety perceptions, breastfeeding concerns, and prior maternal vaccination. Strengthening communication, consistent provider messaging, and targeted support for specific subgroups may be important for the successful implementation of maternal GBS vaccination in Greece.
引用
- Ladomenou F, Gkorla E, Matalliotakis M, et al. Pregnant women's knowledge, perceptions, and intention to receive a future group B Streptococcus (GBS) vaccine: a cross-sectional study. Vaccine. 2026. PMID: 42127547. doi:10.1016/j.vaccine.2026.128706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。